These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2863618)

  • 1. Risk factors in development of liver carcinoma in cirrhosis.
    Bjørneboe M
    Lancet; 1985 Sep; 2(8455):611-2. PubMed ID: 2863618
    [No Abstract]   [Full Text] [Related]  

  • 2. Does a portal-systemic shunt increase the risk of primary hepatic carcinoma in cirrhosis of the liver?
    Bjørneboe M; Andersen JR; Christensen U; Skinhøj P; Jensen OM
    Scand J Gastroenterol; 1985 Jan; 20(1):59-64. PubMed ID: 3992164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis].
    Elizalde JI; Castells A; Planas R; Rodríguez-Iglesias MP; Bruix J; Brú C; Saló J; Boix J; Gassull MA; Terés J; Rodés J
    Gastroenterol Hepatol; 1996 Apr; 19(4):189-93. PubMed ID: 8665355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of TIPS on development of hepatocellular carcinoma in cirrhosis.
    Libbrecht L; Maleux G; Verslype C; Nevens F; Roskams T
    Hepatology; 2005 Jul; 42(1):236; author reply 236-7. PubMed ID: 15892064
    [No Abstract]   [Full Text] [Related]  

  • 5. Cirrhosis and the aetiology of hepatocellular carcinoma.
    Johnson PJ; Williams R
    J Hepatol; 1987 Feb; 4(1):140-7. PubMed ID: 3033058
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.
    Di Costanzo GG
    Hepatology; 2003 Oct; 38(4):1061; author reply 1061. PubMed ID: 14512897
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors and hepatocellular cancer.
    Yu MC; Henderson BE
    Lancet; 1985 Aug; 2(8450):329-30. PubMed ID: 2862491
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?
    Röckelein G; Hecken-Emmel M
    Hepatogastroenterology; 1988 Aug; 35(4):151-7. PubMed ID: 2846418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatocellular carcinoma in cirrhosis. The surgeon's point of view].
    Smadja C; Franco D
    Ann Gastroenterol Hepatol (Paris); 1989; 25(4):129-31. PubMed ID: 2548431
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of double cancer of hepatocellular carcinoma and mucoepidermoid carcinoma of the liver with cirrhosis].
    Minami R; Morita S; Inui A; Oimomi T; Kasuga M; Satonaka K; Maeda S
    Nihon Shokakibyo Gakkai Zasshi; 1992 May; 89(5):1314-8. PubMed ID: 1320144
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma.
    Lai CL; Lok A; Wu PC; Ng M
    Lancet; 1985 Sep; 2(8454):552-3. PubMed ID: 2863566
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Collazos J
    N Engl J Med; 1993 Dec; 329(25):1896-7; author reply 1897-8. PubMed ID: 7504208
    [No Abstract]   [Full Text] [Related]  

  • 13. [The progression of type B liver cirrhosis and the occurrence of hepatocellular carcinoma].
    Higashi T; Urabe Y; Nouso K; Tsuji T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):660-6. PubMed ID: 12442464
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospective study of the development of hepatocellular carcinoma in 160 patients with cirrhosis of the liver].
    Oka H; Kurioka N; Kim K; Kanno T; Harihara S; Yamamoto S; Monna T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2145-50. PubMed ID: 3029471
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma and viral cirrhosis.
    Gentilini P; Melani L; Riccardi D; Casini Raggi V; Romanelli RG
    Hepatology; 1994 Sep; 20(3):764-5. PubMed ID: 8076933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatocellular cancer with a background of liver cirrhosis].
    Zhuravlev VA; Agalakov VI
    Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Braillon A
    Cancer; 2015 Apr; 121(7):1149-50. PubMed ID: 25470258
    [No Abstract]   [Full Text] [Related]  

  • 18. Etiologic factors and clinical presentation of hepatocellular carcinoma: differences between cirrhotic and noncirrhotic Italian patients.
    Nzeako UC
    Cancer; 1995 Sep; 76(5):915. PubMed ID: 8625198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statistical analysis of prognosis in liver cirrhosis with reference to prediction of the high risk group for hepatocellular carcinoma].
    Hanyuda Y
    Nihon Ika Daigaku Zasshi; 1988 Jun; 55(3):279-90. PubMed ID: 2841351
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?
    Flemming JA; Kim WR; Terrault NA
    Cancer; 2015 Apr; 121(7):1150. PubMed ID: 25470366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.